NCT01637805Unknown1 期
Phase 1 Study of Antigen-specific Cytotoxic T Lymphocytes Induced by Dendritic Cells Infected by Recombinant Adeno-associated Virus With CEA Gene in Stage IV Gastric Cancer
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Objective response rate
研究概览
简要总结
The purpose of this study is to evaluate the clinical safety and preliminary efficacy of antigen-specific cytotoxic T lymphocytes induced by dendritic cells infected by recombinant adeno-associated virus with CEA gene in the treatment of stage IV gastric cancer patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Sex: male or female
- •Age: from 18 to 80 years
- •Histology: gastric cancer
- •Clinical stage: stage IV
- •Karnofsky performance status: more than 50%
- •Expected survival: more than 2 months
- •Sex: male or female
- •Laboratory tests results 7 days before the start of treatment:
- •White blood cells: more than 3.0 × 109/L
- •Platelets: more than 100 × 109/L
- •Neutrophils: more than 1.5 × 109/L
- •Hemoglobin: more than 80g/L
- •Serum glutamate pyruvate transaminase: less than 2.5 folds of the upper normal limit (ULN)
- •Serum glutamic-oxal (o) acetic transaminase: less than 2.5 × ULN
- •Serum bilirubin: less than 1.25 × ULN
- •Serum creatinine: less than 1.25 × ULN
- •Pregnancy test: the test of women of child-bearing period must be negative 7 days before the start of treatment
- •Contraception: male and female subjects of child-bearing period must adopt a reliable method of contraception before entry into this study until 30 days after stopping this study
- •Informed consent: subject must have the ability to understand and voluntarily sign a written informed consent
排除标准
- •History of neoplasms: other neoplasms
- •Medical history: mental disease, or congestive heart failure, or severe coronary artery disease, or cardiac arrhythmias, or concomitant corticosteroid therapy
- •Metastasis: clinical symptoms of brain metastasis
- •Other clinical trial: the subject received other clinical trial before this study
- •Laboratory tests: the serum test of human immunodeficiency virus, or hepatitis B virus, or hepatitis C virus was positive
- •Woman: pregnant or lactating women
- •Compliance: poor compliance
结局指标
主要结局
Objective response rate
时间窗: Up to 12 months
CR + PR = ORR
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric CancerGastric CancerNCT02496273The First People's Hospital of Changzhou60
进行中（未招募）
1 期
T-Cell Therapy for Advanced Breast CancerMetastatic HER2-negative BreastBreast CancerNCT02792114Memorial Sloan Kettering Cancer Center186
已完成
1 期
Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID PatientsPediatric PatientsAny Type of Severe Combined Immunodeficiency (SCID)Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)NCT03879876Assistance Publique - Hôpitaux de Paris4
终止
1 期
Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer PatientsBK Virus InfectionCytomegaloviral InfectionHematopoietic and Lymphoid Cell NeoplasmJC Virus InfectionMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-ConfirmedAdenovirus InfectionNCT05101213M.D. Anderson Cancer Center12
已完成
1 期
Administration of Virus-Specific Cytotoxic T-LymphocytesAdenovirus InfectionNCT00590083Baylor College of Medicine14